Denosumab More Cost Effective v Zoledronic Acid in Multiple Myeloma - 102231

Spotlight
Video

Denosumab More Cost Effective v Zoledronic Acid in Multiple Myeloma

Loading........
Description: Noopur Raje, MD of Massachusetts General Hospital Cancer Center outlines how the recently released economic analysis of Denosumab v. Zoledronic Acid found that Denosumab was overall more cost effective. Dr. Raje presented these findings at the 2017 Lymphoma-Myeloma meeting in New York.
Shared By : Lymphoma-Myeloma-Conference
Posted on : 11/06/17
Added : 3 months ago
Category : Multiple Myeloma



Recommended

Nothing found.

More From Lymphoma-Myeloma-Conference

Nothing found.